Search IconSearch

Cleveland Clinic’s Department of Nephrology and Hypertension Named Comprehensive Hypertension Center by the American Heart Association

One of only eight centers recognized nationally


By Robert Heyka, MD and George Thomas, MD


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The American Heart Association has recognized Cleveland Clinic’s Department of Nephrology and Hypertension as a Comprehensive Hypertension Center, and one of only eight centers currently recognized nationally. This designation recognizes institutions that have demonstrated experience and expertise in the management of difficult hypertension cases.

Our Center for Blood Pressure Disorders is staffed with experienced nephrologists and hypertension specialists, along with physician assistants and clinical nurse practitioners.

The center has a dedicated hypertension laboratory with space and equipment devoted to evaluation and testing.

Monitoring Capabilities

Along with the standardized use of automated blood pressure devices in our outpatient clinics, we provide 24-hour ambulatory blood pressure measurements for a large cohort of patients to help assess different blood pressure patterns, in addition to assessment of therapy efficacy.

Central blood pressures have been shown to correlate more strongly with vascular disease than do routine peripheral blood pressure measurements, and we have the ability to assess central blood pressure indices, including measures of pulse wave velocity and augmentation index.

The center also has expertise in the management of secondary hypertension, specifically related to the diagnosis and treatment of primary aldosteronism, pheochromocytoma and renal artery stenosis.

A Collaborative Care Model

The center uses a collaborative approach to diagnosis, care and monitoring of blood pressure disorders. We work closely with internists, cardiologists, endocrinologists and vascular medicine specialists to develop a diagnostic and management plan tailored to the individual patient.

An effective treatment program requires partnership between the patient and care providers. Our center supports patients with information regarding blood pressure monitoring guidelines, lifestyle changes and nutrition.

Dr. Heyka is Chairman of the Department of Nephrology and Hypertension in Cleveland Clinic’s Glickman Urological & Kidney Institute. Dr. Thomas is Director of the Center for Blood Pressure Disorders in the Department of Nephrology and Hypertension.


Related Articles

Man sitting at kitchen table with blood pressure monitor and pill bottles
Should Patients Take Blood Pressure Medications in the Evening to Enhance Cardiovascular Benefit?

Clinicians should individualize dosing practices based on patient risk factors and preferences

Drawing of a pink bulb with two tubes coming out of the top
Predicting Post-Op GFR: AI Algorithm Is as Accurate as Clinical Model

Fully-automated process uses preop CT, baseline GFR to estimate post-nephrectomy renal function

Arm of Black patient having kidney dialysis
GFR Equations: How Will Eliminating the Race Coefficient Affect Black Patients?

Could mean earlier treatment, but also could have negative effects

Senior at the Doctors
Study Assesses the Utility of Renal Genetic Testing in Black Patients

Identifying barriers in the renal genetic assessment of Black patients

GUKI Care Page of Dr. George Thomas and Angela Smith
Resistant Hypertension: A Stepwise Approach

Getting patients to their goal blood pressure

urine bottle held by healthcare professionals with latex glove, toxicology test
Nephrologist-Led Urine Microscopy Edges Out Automated Technology in Predicting AKI

Study highlights benefits of nephrologist-led urine sediment analysis

New Data Suggest Kidney Diseases With No Known Cause May Be Linked to Viruses

Using sequencing data to identify novel factors linked to kidney disease with unknown origin

A 3-Year Review of Real-World Experience in the Renal Genetics Clinic

Program plays key role in diagnosis and management of genetic kidney diseases